ÂÜÀòÂÒÂ×

Etienne Sokal, MD, PhD, is a prominent academic and medical professional serving as Professeur émérite and Professeur Ordinaire at Université catholique de Louvain since September 1983, with a focus on clinical research and education in pediatric gastroenterology and hepatology. Sokal holds key leadership positions at Cliniques Universitaires St Luc, including Head of the Liver Tissue Bank and Chef de Service for Pediatric Gastroenterology & Hepatology, establishing an international referral center for rare liver diseases. As founder and CEO of Cellaïon, Sokal has led advancements in cell therapy for acute on chronic liver failure, following a successful tenure as CEO of Promethera Biosciences where Sokal rescued and restructured the company. Sokal's extensive background in clinical hepatology, coupled with academic credentials including a fellowship at King's College Hospital, underpins a distinguished career dedicated to innovation in liver disease treatment.